Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 17-Oct-2018

CATS Tonometer, LLC

Abstract

Intraocular pressure (IOP) is a key metric in the diagnosis /treatment of glaucoma in addition to other conditions. Glaucoma, which is characterized by high IOP, is the leading cause of irreversible blindness effecting 79.6 million people by 2020. The CATS prism is a FDA (510K) cleared device that produces significantly improved IOP accuracy for 50% of the population over existing prisms. Studies demonstrated the CATS improves IOP accuracy by 94% for this patient population. On a worldwide basis, the CATS prism provides clinicians the sight-saving IOP data required to properly treat their patients with no change in protocol or patient flow by simply changing out the legacy prism with either the CATS reusable prism (every 3-5 years) or the CATS disposable prism (with each patient).

Photos

Additional Questions

Investor questions have not yet been answered for this business